Document:

Amended and Restated Strategic Advisory Services Agreement - Lit Tele LLC

 Exhibit 10.10 

AMYRIS BIOTECHNOLOGIES, INC. 

AMENDED AND RESTATED 

STRATEGIC ADVISORY SERVICES AGREEMENT 

THIS AMENDED AND RESTATED STRATEGIC ADVISORY SERVICES AGREEMENT (“Agreement”) is made and entered
into as of July 31, 2009 (the “Amendment Date”), by and between Amyris Biotechnologies, Inc., a California corporation having its principal place of business located at 5885 Hollis Street, Suite 100, Emeryville, CA 94608, USA
(“Amyris”), and Lit Tele LLC, a Delaware limited liability company, with its registered office at 3411 Silverside Road, Rodney Building #104, in the City of Wilmington, State of Delaware (“Lit Tele”). This Agreement
amends and restates in its entirety that certain Strategic Advisory Services Agreement by and between Amyris and Lit Tele dated September 15, 2008 (the “Effective Date”). 

RECITALS 

WHEREAS, Amyris is a biotechnology company engaged in the business of developing innovative products using techniques of
synthetic biology (the “Amyris Technology”); and 
 WHEREAS, Amyris is currently developing the
Amyris Technology for the production and distribution of, among other things, hydrocarbon transportation fuels from sugarcane feedstock in a variety of countries around the world, including Brazil; and 

WHEREAS, Amyris, together with Crystalsev Comércio e Representação Ltda., a limited liability
company organized and existing under the laws of Brazil, have formed a Brazilian limited liability company called Amyris do Brasil Pesquisa e Desenvolvimento de Biocombustíveis Ltda. (“ACB”), for the purpose of (i) using
the Amyris Technology to manufacture hydrocarbon transportation fuels from sugarcane feedstock within the country of Brazil, and (ii) trading such hydrocarbon transportation fuels within the country of Brazil and/or abroad; and 

WHEREAS, Lit Tele, as a wholly-owned subsidiary of Votorantim Novos Negócios Ltda (“VNN”) the
venture capital and private equity arm of the Votorantim Group, has extensive knowledge, experience and expertise in advising agricultural-related businesses of the type Amyris and ACB are engaged, and VNN, as the 100% owner of Lit Tele, desires
that Lit Tele invest in shares of Series C Preferred Stock of Amyris (the “Series C Financing”); and 

WHEREAS, as a condition of such investment by Lit Tele, Amyris desires to engage Lit Tele as a consultant to render
consultancy services to Amyris and ACB upon the terms and conditions hereinafter set forth; and 
 WHEREAS, the
services provided under this Agreement are intended to be provided and received in a way such that the value of Amyris and ACB are preserved and maximized. 

NOW THEREFORE, in consideration of the foregoing recitals and the mutual promises and covenants contained in this
Agreement, the parties hereto agree as follows: 

 AGREEMENT 

1. Strategic Advisory Services. Lit Tele agrees to render strategic advisory services to Amyris in connection with
Amyris’ business activities in Brazil and other jurisdictions outside the United States (the “Strategic Advisory Services”). The parties agree, by way of illustration and not limitation, that such Strategic Advisory Services
will include serving as a strategic advisor to ACB. VNN, Lit Tele and Amyris agree that Fernando Reinach, an Executive Director of VNN, will provide such Strategic Advisory Services, unless otherwise agreed by Amyris in writing 

2. Compensation and Expenses. 

(a) Equity Compensation. During the term of this Agreement, as compensation for the Strategic Advisory
Services rendered and other obligations undertaken by Lit Tele hereunder, Lit Tele shall receive: 
 (i) An
initial grant of fifty thousand (50,000) restricted stock units (“RSUs”) which shall be issued and shall, except as specified under Sections 6(b) and 6(c) herein, vest in accordance with the terms and conditions set forth in
the Restricted Stock Unit Issuance Agreement, as amended, by and between Amyris and Lit Tele and dated September 15, 2008 (the “Initial RSU Grant”). 

(ii) Immediately following each closing of Amyris’ Series C Financing, an additional grant of that number of RSUs
equal to that number of RSUs required to bring Lit Tele (together with any of its affiliates, including the Votorantim Group) to an equity ownership level, including all shares of Amyris preferred stock, common stock, or securities exercisable for
or convertible into Amyris preferred or common stock, including RSUs, then held by Lit Tele (together with any of its affiliates) of 5% of the Fully-Diluted Capitalization (as defined below) of Amyris following such closing (the “Additional
RSU Grants,” and together with the Initial RSU Grant, the “RSU Grants”). The Additional RSU Grants shall vest, except as specified under Sections 6(b) and 6(c) herein, in accordance with the terms and conditions set forth
in the Restricted Stock Unit Issuance Agreement attached hereto as Exhibit A. “Fully-Diluted Capitalization” means the sum of (A) the number of shares of common stock then outstanding, (B) the number of shares of
preferred stock then outstanding, (C) the number of shares of capital stock directly issuable upon exercise for cash of warrants then outstanding, (D) the number of shares of common stock issuable upon exercise of then outstanding options,
and (E) the number of shares of common stock then available for issuance under the Company’s 2005 Stock Option/Stock Issuance Plan, in each case calculated without duplication with the other clauses in this sentence. 

Such RSU Grants shall be inclusive of all fees and expenses and, except as set forth below or otherwise agreed by Amyris in writing,
shall be Lit Tele’s sole compensation for rendering the Strategic Advisory Services to Amyris. The parties hereto intend that the RSU Grants shall be without withholding or deduction for any U.S. tax. 

(b) Amyris shall reimburse Lit Tele for all travel expenses incurred in connection with travel undertaken by Lit Tele in
connection with this Agreement. Such reimbursement shall be made upon receipt and verification by Amyris of customary receipts and vouchers. 

3. Lit Tele’s Representations, Warranties and Obligations. 

(a) The parties will perform their obligations under this Agreement as independent contractors and nothing contained in
this Agreement will be construed to be inconsistent with such relationship or status. This Agreement will not constitute, create or in any way be interpreted as an agency relationship or a joint venture or partnership of any kind. Nothing in this
Agreement shall be interpreted or construed 
  

 2 

 
as creating or establishing an employment relationship between Amyris and VNN’s or Lit Tele’s personnel. Payment of all income taxes due on any amounts paid to Lit Tele hereunder will
be the sole responsibility of Lit Tele. 
 (b) Lit Tele’s performance under this Agreement shall be
conducted with due diligence and in full compliance with the highest professional standards of practice in the industry. For performing its duties under the Agreement, Lit Tele shall, to the extent necessary, use its own tools and equipment.

 (c) Lit Tele certifies that Lit Tele has no outstanding agreement or obligation that is in conflict with any
of the provisions of this Agreement, or that would preclude Lit Tele from complying with the provisions hereof and further certifies that Lit Tele will not enter into any such conflicting agreement during the term of this Agreement. In connection
therewith, VNN will not, and will cause its majority-owned subsidiaries not to, without the prior written approval from the Chief Executive Officer of Amyris, engage in any business or activity that is competitive with the business conducted by or
known to VNN as demonstrably anticipated by Amyris on the date hereof, and VNN will not, and will cause its majority-owned subsidiaries not to, assist any other person or organization in competing with Amyris, or in preparing to engage in
competition with any business conducted by or known to VNN as demonstrably anticipated by Amyris on the date hereof. 

4.Confidentiality. 

(a) Definition. “Proprietary Information” means the Strategic Advisory Services to be provided by
Lit Tele hereunder and the results thereof, as well as all information that has been or will be disclosed to Lit Tele by or on behalf of Amyris, directly or indirectly, or is obtained or observed by Lit Tele from Amyris while providing Strategic
Advisory Services hereunder, whether in written, oral, visual, graphic, electronic or other form, including, without limitation, the identity, structure, chemical formula and composition of any materials in research or development by Amyris;
procedures and formulations for producing any such materials; any related trade secrets, data, reports, analyses, ideas or inventions; information relating to the regulatory status of any such materials; financial or personnel matters relating to
Amyris; information relating to Amyris’ sales, marketing, suppliers, clients, customers, investors or business; and all such information of any third party from which Amyris has received such information on a confidential basis. Notwithstanding
the foregoing, Proprietary Information does not include any technology, invention, trade secret or know-how and any materials, documents, programs or information owned, controlled by or licensed to Lit Tele, at the date of this Agreement, or
developed by Lit Tele independently of this Agreement, without use of or reference to any Proprietary Information, whether patentable or not (hereinafter referred to as “Lit Tele Technology”). 

(b) Use. Proprietary Information may be used by Lit Tele only to the extent required to perform the Strategic
Advisory Services and will not be used for any other purpose without the express prior written consent of Amyris, to be given or withheld in Amyris’ absolute discretion. Proprietary Information will not be used, reproduced or distributed in
whole or in part in any form except as required to perform the Strategic Advisory Services. 
 (c)
Nondisclosure. Lit Tele agrees to maintain all Proprietary Information in confidence and not to disclose Proprietary Information to any third party without the express prior written consent of Amyris, to be given or withheld in Amyris’
absolute discretion. In this regard, Lit Tele agrees to disclose Proprietary Information only to those of its employees, agents and consultants who are directly involved in the performance of the Strategic Advisory Services and have a need to see
such Proprietary Information to enable Lit Tele to perform the Strategic Advisory Services, and who are bound by written obligations of confidentiality at least as stringent as those set forth herein. Lit Tele will advise its employees, agents and
consultants of the confidential nature of the Proprietary Information and agrees 
  

 3 

 
to be responsible for any breach of the provisions of this Agreement by such employees, agents and consultants. 

(d) Protection. Lit Tele agrees to take all reasonable precautions to protect the confidentiality of Proprietary
Information and to prevent its disclosure to and use by any unauthorized third party. Lit Tele further agrees to notify Amyris, promptly and in writing, of any actual or suspected misappropriation or unauthorized use or disclosure of the Proprietary
Information that may come to Lit Tele’s attention. 
 (e) Exceptions. Notwithstanding the above, Lit
Tele will not have liability to Amyris under this Article 4 with regard to the use or disclosure of any information that Lit Tele can demonstrate by competent written proof: (i) is now, or hereafter becomes, generally known or available to the
public through no act or failure to act on the part of Lit Tele; (ii) is known by Lit Tele as a matter of legal right, without restriction on use or disclosure, at the time of receiving such information; (iii) is hereafter furnished to Lit
Tele by a third party, as a matter of legal right and without restriction on disclosure, and not on Amyris’ behalf; or (iv) is independently developed by Lit Tele without use of or reference to Proprietary Information. Specific information
disclosed as part of the Proprietary Information will not be deemed to fall within the foregoing exclusions merely because certain individual features are published or available to the general public or in the rightful possession of Lit Tele unless
the combination as a whole falls within any of the above exceptions. 
 (f) Return of Materials. All
Proprietary Information (including all summaries and whole or partial copies thereof) is and will at all times remain the property of Amyris and will be returned to Amyris by Lit Tele upon the request of Amyris and, in any event, upon the expiration
or termination of this Agreement. 
 (g) Third Party Information. Lit Tele will not disclose or otherwise
make available to Amyris in any manner any confidential information of Lit Tele or any confidential information received by Lit Tele from third parties, unless Amyris first agrees in writing to receive such information. 

(h) Remedies. Lit Tele acknowledges that its obligations under this Article 4 are necessary and reasonable to
protect the Proprietary Information and expressly agrees that monetary damages would be inadequate to compensate Amyris for the breach of any of the terms and conditions of this Article 4. In addition to any other remedies that may be available, in
law, in equity, or otherwise, Amyris may be entitled to injunctive relief against any threatened material breach of Article 4 of this Agreement or the continuation of any material breach without the necessity of proving actual damages. 

5. Intellectual Property. 

(a) Intellectual Property. All information, inventions, discoveries, innovations, suggestions, ideas,
communications, correspondence, notes, reports, data, records and results, whether or not copyrightable or patentable, conceived, reduced to practice, made, observed or developed by Lit Tele or its employees or agents, solely or jointly with others,
as a result of performing the Strategic Advisory Services relating to Amyris’ Proprietary Information, together with all intellectual property rights related thereto (collectively, the “Inventions”) will be and remain at all
times the property of Amyris. For the avoidance of doubt, Inventions do not include any Lit Tele IP (as defined in subsection (e) below). 

(b) Records. Lit Tele agrees to keep and maintain adequate and current written records of all Inventions made by
Lit Tele (solely or jointly with others) during the term of this Agreement. The records will be in the form of notes, sketches, drawings, and any other format that may be specified by Amyris. The records will be available to and remain the sole
property of Amyris at all times. Lit Tele will promptly and fully disclose all Inventions to Amyris and will treat all Inventions and records related 

 

 4 

 
thereto as Proprietary Information of Amyris. 
 (c)
Assignment. Lit Tele hereby assigns to Amyris, without further consideration, all of Lit Tele’s right, title and interest in and to all such Inventions. At Amyris’ request and expense, as Amyris deems necessary or appropriate, Lit
Tele will perform, or cause its employees and agents to perform, any and all acts necessary to assist Amyris in perfecting Amyris’ right, title and interest in and to such Inventions. Such acts will include but not be limited to executing all
papers, including, without limitation, all documents associated with the filing and prosecution of patent applications, invention assignments and copyright assignments, and providing affidavits or testimony in connection with patent interference,
validity or infringement proceedings and participating in other legal proceedings. Reasonable costs related to such assistance, if required, will be paid by Amyris. Lit Tele represents and warrants to Amyris that all of its employees and agents
performing Strategic Advisory Services hereunder are required to assign all of their right, title and interest in and to any Inventions to Lit Tele. To the extent that any of the Inventions may not as a matter of law be assigned or transferred to
Amyris, or if Lit Tele should, by operation of law or otherwise, hereafter recover, any right, title or interest in or to the Inventions, Lit Tele shall grant to Amyris and its successors and assigns a freely assignable, irrevocable, exclusive,
worldwide, royalty-free right and license to all such Inventions with unfettered rights to grant sublicenses. 

(d) No Rights Granted. Nothing in this Agreement will be construed as granting Lit Tele, either expressly or by
implication, any type of right or license under any intellectual property right or other right of Amyris other than the limited right solely as necessary to enable Lit Tele to perform the Strategic Advisory Services; nor will this Agreement grant
Lit Tele any rights in or to the Proprietary Information other than the limited right to use the Proprietary Information solely to perform the Strategic Advisory Services. This Agreement imposes (i) no obligation on Amyris to disclose any
Proprietary Information, which will be provided or disclosed, if at all, at Amyris’ sole discretion; and (ii) no obligation for either party to enter into any further agreement with the other party. 

(e) Lit Tele IP. Lit Tele shall not, without Amyris’ prior written consent, incorporate into Intellectual
Property developed by Lit Tele in the course of performing the Strategic Advisory Services for Amyris (“Amyris IP”) any invention, improvement, development, concept, discovery or other proprietary information that is either owned by
Lit Tele or in which Lit Tele has an interest (“Lit Tele IP”). In the event Lit Tele does knowingly incorporate any Lit Tele IP into Amyris IP without Amyris’ prior written consent, Lit Tele hereby grants Amyris a nonexclusive,
fully paid up, royalty-free, perpetual, irrevocable, worldwide license to make, have made, modify, use, offer for sale, sell or import such Lit Tele IP as part of or in connection with such Amyris IP. 

(f) Third Party IP. Lit Tele shall not, without Amyris’ prior written consent, incorporate into Amyris IP any
invention, improvement, development, concept, discovery or other proprietary information that Lit Tele knows is owned by any third party (“Third Party IP”). To the extent Lit Tele does incorporate any Third Party IP into Amyris IP
without Amyris’ prior written consent, Lit Tele shall use its best efforts to cause the third part(y)(ies) who own or have the power to control the disposition of such Third Party IP to grant Amyris a license of the same scope as that set forth
in subsection (e) above. 
 6. Term and Termination. 

(a) This Agreement will commence on the Effective Date and will continue for three (3) years unless terminated as
provided herein. 
 (b) Amyris may terminate this Agreement for convenience effective upon thirty (30) days
written notice to Lit Tele. In the event that Amyris terminates this Agreement pursuant to this Section 6(b), any 

 

 5 

 
unvested portion of the RSU Grants shall become immediately vested as of the date of such termination and the Shares (as defined in the Restricted Stock Unit Issuance Agreement attached hereto as
Exhibit A) subject to those vested units shall be issued immediately upon such vesting. 
 (c) In the event that
Fernando Reinach ceases to provide the Strategic Advisory Services for any reason, (i) the pro rata portion of the RSU Grants which is unvested at the date of such cessation shall immediately become vested and the Shares (as defined in the
Restricted Stock Unit Issuance Agreement attached hereto as Exhibit A) subject to those vested units shall be issued to Lit Tele immediately upon such vesting, (ii) the remainder of the unvested portion of the RSU Grants shall be forfeited and
canceled, and (iii) none of the parties to this Agreement shall be liable to any of the other parties for terminating this Agreement in accordance with this provision. 

(d) Either party may terminate this Agreement effective immediately upon written notice in the event the other party
breaches or defaults under any provision of this Agreement. 
 (e) Articles 4, 5, 6 and 7 shall survive
termination of this Agreement. 
 7. General Provisions. 

(a) This Agreement will be governed by the laws of the State of California, as such laws are applied to contracts entered
into and to be performed within such state, without regard to any conflicts of laws provisions. For purposes of Brazilian conflict of law rules, the Parties acknowledge and agree that Amyris is the proponent of the transaction embodied herein.

 (b) This Agreement sets forth the entire agreement and understanding between Amyris and Lit Tele relating to
the subject matter herein and supersedes all prior discussions between the parties. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless executed in writing and signed by both
parties. 
 (c) All notices required or given herewith shall be addressed to Amyris or Lit Tele at the
designated addresses shown below by registered mail, special delivery, or by certified courier service: 

If to Lit Tele: 

Rua Jeronimo da Vega, 384-12o andar 

São Paulo, Brazil 

Attn: Fernando Reinach 

Fax: +55 (11) 3077-5051 

Email: fernando.reinach@vnnegocios.com.br 

If to Amyris: 

Amyris Biotechnologies, Inc. 

5885 Hollis Street, Suite 100 

Emeryville, CA 94608 

USA 

Attn: Legal Department 

Fax: (510) 842-1460 

Email: tompkins@amyrisbiotech.com 
  

 6 

 (d) The headings used in this Agreement are for the convenience of the
parties and for reference purposes only and shall not form a part or affect the interpretation of this Agreement. 

(e) If one or more of the provisions in this Agreement are deemed void by law, then the remaining provisions will
continue in full force and effect. 
 (f) Neither this Agreement nor any right hereunder or interest herein may
be assigned or transferred by Lit Tele without the express prior written consent of an officer of Amyris. This Agreement will be binding upon Lit Tele’s heirs, executors, administrators and other legal representatives and will be for the
benefit of Amyris, its successors, and its assigns. 
 (g) If any action at law or in equity is necessary to
enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs, and necessary disbursements, in addition to any other relief to which the party may be entitled. 

[Signature Page Follows] 
  

 7 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the day and year first above written. 
 LIT TELE LLC 

By:       /s/ Paulo Henrique de Oliveira Santos 

Name:  Paulo Henrique de Oliveira Santos 

Title:   Authorized Signatory 

By:      /s/ Fernando
Reinach                         

Name:  Fernando C. Reinach 

Title:   Authorized Signatory 

Place and Date: _________________________ 

WITNESSES: 

 

 1. _____________________________________ 

Name:

 2. ____________________________________ 

Name: 

  
 AMYRIS
BIOTECHNOLOGIES, INC.  
 By:       /s/ Tamara L. Tompkins 

Name:  Tamara L. Tompkins 

Title:    General Counsel 

Place and Date:Sao Paulo, Brazil 29 July
2009                     

WITNESSES: 

 

 1. _____________________________________ 

Name: 

 

 2. ____________________________________ 

Name: 

  

STRATEGIC ADVISORY SERVICES AGREEMENT 

SIGNATURE PAGE 

 VOTORANTIM NOVOS NEGÓCIOS LTDA, 

as a party solely for purposes of Article 1 and Sections 3(c) and 7(a) 

By:          /s/ Paulo Henrique de Oliveira Santos
        /s/ Fernando Reinach 
 Name:     Paulo Henrique de
Oliveira Santos         Fernando Reinach 
 Place and Date:
_________________________ 
 WITNESSES: 

 

 1. _____________________________________ 

Name: 

 

 2. ____________________________________ 

Name: 

  
  

 
 STRATEGIC ADVISORY
SERVICES AGREEMENT 
 SIGNATURE PAGE 

 EXHIBIT A 

Form of Restricted Stock Unit Agreement 

AMYRIS BIOTECHNOLOGIES, INC. 

RESTRICTED STOCK UNIT ISSUANCE AGREEMENT 

1.     Grant of Restricted Stock Units.    The Corporation hereby
awards to the Participant, as of the Award Date, Restricted Stock Units. Each Restricted Stock Unit which vests pursuant to the vesting schedule set forth below shall entitle Participant to receive one share of Common Stock on the specified issuance
date. The number of shares of Common Stock subject to the awarded Restricted Stock Units, the applicable vesting schedule for those shares, the date on which those vested shares shall become issuable to Participant and the remaining terms and
conditions governing the award (the “Award”) shall be as set forth in this Agreement. All capitalized terms in this Agreement shall have the meaning assigned to them in the attached Appendix A. 

AWARD SUMMARY 
  

			
	 Participant:
	  	 Lit Tele LLC

		
	 Award Date:
	  	 [____]

		
	 Number of Shares Subject to Award:
	  	 The maximum number of shares of Common Stock subject to this Award is [_______] (the “Shares”). However, the actual number of shares of Common Stock
issuable pursuant to this Award shall be determined in accordance with the Vesting Schedule set forth below.

		
	 Vesting Schedule:
	  	 The Shares shall vest in a series of four (4) successive equal quarterly installments at the end of each fiscal quarter over the one (1)-year period measured
from July __, 2009, provided Participant remains in the Corporation’s Service through each such vesting date. However, the Shares may be subject to accelerated vesting in whole or in part in accordance with the provisions of Paragraph 5 of this
Agreement.

		
	 Issuance

Schedule
	  	 Each Share in which Participant vests in accordance with the Vesting Schedule shall be issued, subject to Paragraph 8 of this Agreement and the
Corporation’s collection of all applicable Withholding Taxes, on the date that particular Share vests (the “Issuance Date”) or as soon after that scheduled Issuance Date as administratively practicable. The Shares which vest pursuant
to Paragraph 5 of this Agreement shall be issued in accordance with the provisions of such Paragraph. In addition, any issued Shares shall be subject to the transfer restrictions of this
Agreement.

			
		  	 In no event shall any fractional shares be issued. Accordingly the total number of Shares to be issued pursuant to the Award shall, to the extent necessary,
be rounded down to the next whole Share.

 2.    Limited
Transferability.    Prior to actual receipt of the Shares which vest and become issuable hereunder, Participant may not transfer any interest in the Award or the underlying Shares; however, the foregoing shall not apply
to any transfer of interest in the Award or the underlying shares without consideration to any person or entity, directly or indirectly, controlling, controlled by or under common control with, the Participant, provided that (A) the Participant
shall inform the Corporation of such transfer prior to effecting it and (B) the transferee shall enter into a written agreement to be bound by and comply with all provisions of this Agreement, as if it were the original participant hereunder.
Any issued Shares shall be subject to the restrictions of Paragraphs 9 and 10 of this Agreement. In addition, Participant shall make no disposition of any issued Shares unless and until there is compliance with all of the following requirements:
(i) Participant shall have provided the Corporation with a written summary of the terms and conditions of the proposed disposition; (ii) Participant shall have complied with all requirements of this Agreement applicable to the disposition
of the Shares; and (iii) Participant shall have provided the Corporation with written assurances, in form and substance satisfactory to the Corporation, that (a) the proposed disposition does not require registration of the Shares under
the 1933 Act or (b) all appropriate action necessary for compliance with the registration requirements of the 1933 Act or any exemption from registration available under the 1933 Act (including Rule 144) has been taken. 

3.    Cessation of Service.    Should Participant cease Service
for any reason prior to vesting in one or more Shares subject to this Award, then the Award will be immediately cancelled with respect to those unvested Shares, and the number of Restricted Stock Units will be reduced accordingly. Participant shall
thereupon cease to have any right or entitlement to receive any Shares under those cancelled units. Should Participant’s Service terminate by reason of Misconduct, then this Award will be immediately cancelled with respect to all the Restricted
Stock Units subject to such Award, whether vested or unvested at the time, and Participant shall thereupon cease to have any right or entitlement to receive any Shares under this Award and the cancelled Restricted Stock Units. 

4.     Stockholder Rights.    The holder of this Award shall not
have any stockholder rights, including voting or dividend rights, with respect to the Shares subject to the Award until Participant becomes the record holder of those Shares following their actual issuance upon the Corporation’s collection of
the applicable Withholding Taxes. 
 5.    Change of Control. 

(a) Any Restricted Stock Units subject to this Award at the time of a Change in Control may be assumed by the successor
entity or otherwise continued in full force and effect or may be replaced with a cash incentive program of the successor entity which preserves the Fair Market Value of the unvested shares of Common Stock subject to the Award at the time of the
Change in Control and provides for subsequent payout of that 
  

 2 

 
value in accordance with the vesting schedule applicable to the Award. In the event of such assumption or continuation of the Award or such replacement of the Award with a cash incentive program,
no accelerated vesting of the Restricted Stock Units shall occur at the time of the Change in Control. 
 (b)
In the event the Award is assumed or otherwise continued in effect, the Restricted Stock Units subject to the Award shall be adjusted immediately after the consummation of the Change in Control so as to apply to the number and class of securities
into which the Shares subject to those units immediately prior to the Change in Control would have been converted in consummation of that Change in Control had those Shares actually been issued and outstanding at that time. To the extent the actual
holders of the outstanding Common Stock receive cash consideration for their Common Stock in consummation of the Change in Control, the successor corporation (or parent entity) may, in connection with the assumption or continuation of the Restricted
Stock Units subject to the Award at that time and with Participant’s prior written consent, substitute one or more shares of its own common stock with a fair market value equivalent to the cash consideration paid per share of Common Stock in
the Change in Control transaction, provided the substituted common stock is readily tradable on an established U.S. securities exchange or market. 

(c) If the Restricted Stock Units subject to this Award at the time of the Change in Control are not assumed or
otherwise continued in effect or replaced with a cash incentive program under Section 6(a), then those units will vest immediately prior to the closing of the Change in Control. The Shares subject to those vested units will be issued
immediately upon such vesting (or otherwise converted into the right to receive the same consideration per share of Common Stock payable to the other stockholders of the Corporation in consummation of that Change in Control), subject to the
Corporation’s collection of the applicable Withholding Taxes. 
 (d) This Agreement shall not in any way
affect the right of the Corporation to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets. 

6.    Adjustment in Shares.    Should any change be made to the
Common Stock by reason of any stock split, stock dividend, recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without the Corporation’s receipt of consideration,
appropriate adjustments shall be made to the total number and/or class of securities issuable pursuant to this Award in order to reflect such change and thereby preclude a dilution or enlargement of benefits hereunder. 

 

 3 

 7.    Compliance with Laws and
Regulations.    The issuance of shares of Common Stock pursuant to the Award shall be subject to compliance by the Corporation and Participant with all applicable requirements of law relating thereto and with all
applicable regulations of any Stock Exchange on which the Common Stock may be listed for trading at the time of such issuance. 

8.    Representations.     the time of issuance of the Shares,
Participant shall, if required by the Corporation, deliver to the Corporation Participant’s Investment Representation Statement in the form attached hereto as Exhibit A. 

9.    Market Stand-Off. 

(a) In connection with any underwritten public offering by the Corporation of its equity securities pursuant to an
effective registration statement filed under the 1933 Act, including the Corporation’s initial public offering, Participant shall not sell, make any short sale of, loan, hypothecate, pledge, grant any option for the purchase of, or otherwise
dispose or transfer for value or otherwise agree to engage in any of the foregoing transactions with respect to, any issued Shares without the prior written consent of the Corporation or its underwriters. Such restriction (the “Market
Stand-Off”) shall be in effect for such period of time from and after the effective date of the final prospectus for the offering as may be requested by the Corporation or such underwriters. In no event, however, shall such period exceed one
hundred eighty (180) days, and the Market Stand-Off shall in no event be applicable to any underwritten public offering effected more than two (2) years after the effective date of the Corporation’s initial public offering.

 (b) Participant shall be subject to the Market Stand-Off provided and only if the officers and
directors of the Corporation are also subject to similar restrictions. 
 (c) Any new, substituted or
additional securities which are by reason of any Recapitalization or Reorganization distributed with respect to the issued Shares shall be immediately subject to the Market Stand-Off, to the same extent the issued Shares are at such time covered by
such provisions. 
 (d) In order to enforce the Market Stand-Off, the Corporation may impose stop-transfer
instructions with respect to the issued Shares until the end of the applicable stand-off period. 

10.    Right of First Refusal 

(a) Grant.    The Corporation is hereby granted the right of
first refusal (the “First Refusal Right”), exercisable in connection with any proposed transfer of the Shares. For purposes of this Section 10, the term “transfer” shall include any sale, assignment, pledge, encumbrance or
other disposition of the Shares intended to be made by Participant. 
  

 4 

 (b) Notice of Intended
Disposition.    In the event Participant desires to accept a bona fide third-party offer for the transfer of any or all of such shares (the Shares subject to such offer to be hereinafter referred to as the
“Target Shares”), Participant shall promptly (i) deliver to the Corporation written notice (the “Disposition Notice”) of the terms of the offer, including the purchase price and the identity of the third-party offeror, and
(ii) provide satisfactory proof that the disposition of the Target Shares to such third-party offeror would not be in contravention of the provisions of this Agreement. 

(c) Exercise of the First Refusal Right.    The Corporation
shall, for a period of twenty-five (25) days following receipt of the Disposition Notice, have the right to repurchase any or all of the Target Shares subject to the Disposition Notice upon the same terms as those specified therein or upon such
other terms (not materially different from those specified in the Disposition Notice) to which Participant consents. Such right shall be exercisable by delivery of written notice (the “Exercise Notice”) to Participant prior to the
expiration of the twenty-five (25)-day exercise period. If such right is exercised with respect to all the Target Shares, then the Corporation shall effect the repurchase of such shares, including payment of the purchase price, not more than five
(5) business days after delivery of the Exercise Notice; and at such time the certificates representing the Target Shares shall be delivered to the Corporation. 

Should the purchase price specified in the Disposition Notice be payable in property other than cash or evidences of
indebtedness, the Corporation shall have the right to pay the purchase price in the form of cash equal in amount to the value of such property. If Participant and the Corporation cannot agree on such cash value within ten (10) days after the
Corporation’s receipt of the Disposition Notice, the valuation shall be made by an appraiser of recognized standing selected by Participant and the Corporation or, if they cannot agree on an appraiser within twenty (20) days after the
Corporation’s receipt of the Disposition Notice, each shall select an appraiser of recognized standing and the two (2) appraisers shall designate a third appraiser of recognized standing, whose appraisal shall be determinative of such
value. The cost of such appraisal shall be shared equally by Participant and the Corporation. The closing shall then be held on the later of (i) the fifth (5th) business day following delivery of the Exercise Notice or (ii) the
fifth (5th) business day after such valuation shall have been made. 
 (d) Non-Exercise of
the First Refusal Right.    In the event the Exercise Notice is not given to Participant prior to the expiration of the twenty-five (25)-day exercise period, Participant shall have a period of thirty
(30) days thereafter in which to sell or otherwise dispose of the Target Shares to the third-party offeror identified in the Disposition Notice upon terms (including the purchase price) no more favorable to such third-party offeror than those
specified in the Disposition Notice; provided, however, that any such sale or disposition must not be effected in contravention of the provisions of Paragraphs 2, 9 and 11 of this Agreement. The third-party offeror shall acquire the Target
Shares subject to the First Refusal Right and the provisions and restrictions of Paragraphs 2, 9 and 11, and any subsequent disposition of the acquired shares must be effected in compliance with the terms and conditions of such First Refusal Right
and the provisions and restrictions of Paragraphs 2, 9 and 11. In the event Participant does not effect such sale or disposition of the Target Shares within the specified thirty (30)-day period, the First Refusal Right shall

  

 5 

 
continue to be applicable to any subsequent disposition of the Target Shares by Participant until such right lapses. 

(e) Partial Exercise of the First Refusal Right. In the event the Corporation makes a
timely exercise of the First Refusal Right with respect to a portion, but not all, of the Target Shares specified in the Disposition Notice, Participant shall have the option, exercisable by written notice to the Corporation delivered within five
(5) business days after Participant’s receipt of the Exercise Notice, to effect the sale of the Target Shares pursuant to either of the following alternatives: 

(i)        sale or other disposition of all the Target Shares to
the third-party offeror identified in the Disposition Notice, but in full compliance with the requirements of Section 10(d), as if the Corporation did not exercise the First Refusal Right; or 

(ii)        sale to the Corporation of the portion of the Target
Shares which the Corporation has elected to purchase, such sale to be effected in substantial conformity with the provisions of Section 10(c). The First Refusal Right shall continue to be applicable to any subsequent disposition of the
remaining Target Shares until such right lapses. 
 Participant’s failure to deliver timely notification
to the Corporation shall be deemed to be an election by Participant to sell the Target Shares pursuant to alternative (i) above. 

(f) Recapitalization/Reorganization. 

(i)        Any new, substituted or additional securities or
other property which is by reason of any Recapitalization distributed with respect to the issued Shares shall be immediately subject to the First Refusal Right, but only to the extent the issued Shares are at the time covered by such right.

 (ii)        In the event of a Reorganization, the
First Refusal Right shall remain in full force and effect and shall apply to the new capital stock or other property received in exchange for the issued Shares in consummation of the Reorganization, but only to the extent the issued Shares are at
the time covered by such right. 
 (g) Lapse. The First Refusal Right shall
lapse upon the earliest to occur of (i) the first date on which shares of the Common Stock are held of record by more than five hundred (500) persons, (ii) a determination made by the Board that a public market exists for the
outstanding shares of Common Stock or (iii) a firm commitment underwritten public offering, pursuant to an effective registration statement under the 1933 Act, covering the offer and sale of the Common Stock in the aggregate amount of at least
twenty million dollars ($20,000,000). However, the Market Stand-Off shall continue to remain in full force and effect following the lapse of the First Refusal Right. 

 

 6 

 (h) No
Waiver.    The failure of the Corporation in any instance to exercise the First Refusal Right shall not constitute a waiver of any other repurchase rights and/or rights of first refusal that may subsequently
arise under the provisions of this Agreement or any other agreement between the Corporation and Participant. No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition,
whether of like or different nature. 
 (i) Cancellation of
Shares.     If the Corporation shall make available, at the time and place and in the amount and form provided in this Agreement, the consideration for the Shares to be repurchased in accordance with the
provisions of this Agreement, then from and after such time, the person from whom such shares are to be repurchased shall no longer have any rights as a holder of such shares (other than the right to receive payment of such consideration in
accordance with this Agreement). Such shares shall be deemed purchased in accordance with the applicable provisions hereof, and the Corporation shall be deemed the owner and holder of such shares, whether or not the certificates therefor have been
delivered as required by this Agreement. 
 (j) Exempted
Transfers.     Notwithstanding the foregoing, the First Refusal Right of the Corporation set forth in this Section 10 shall not apply to any transfer without consideration to any person or entity,
directly or indirectly, controlling, controlled by or under common control with the Participant; provided that (A) the Participant shall inform the Corporation of such transfer prior to effecting it and (B) the transferee shall enter into
a written agreement to be bound by and comply with all provisions of this Agreement, as if it were the original participant hereunder. Such transferred Shares shall remain “Shares” hereunder, and such transferee shall be treated as the
“Participant” for purposes of this Agreement. 
 11. Restrictive Legends and Refusal to
Transfer. 
 (a) The stock certificates for the Shares shall be endorsed with one or more of the
following restrictive legends: 
 “The shares represented by this certificate have not been registered
under the Securities Act of 1933. The shares may not be sold or offered for sale in the absence of (a) an effective registration statement for the shares under such Act, (b) a ‘no action’ letter of the Securities and Exchange
Commission with respect to such sale or offer or (c) satisfactory assurances to the Corporation that registration under such Act is not required with respect to such sale or offer.” 

 

 7 

 “The shares represented by this certificate are subject to certain rights of first
refusal granted to the Corporation and accordingly may not be sold, assigned, transferred, encumbered, or in any manner disposed of except in conformity with the terms of a written agreement dated September [ ], 2008, between the Corporation and the
registered holder of the shares (or the predecessor in interest to the shares). A copy of such agreement is maintained at the Corporation’s principal corporate offices.” 

(b) The Corporation shall not be required (i) to transfer on its books any Shares which have been sold or
transferred in violation of the provisions of this Agreement or (ii) to treat as the owner of the Shares, or otherwise to accord voting, dividend or liquidation rights to, any transferee to whom the Shares have been transferred in contravention
of this Agreement. 
 12. Notices.    Any notice required to be given or
delivered to the Corporation under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal corporate offices. Any notice required to be given or delivered to Participant shall be in writing and addressed to
Participant at the address indicated below Participant’s signature line on this Agreement. All notices shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, postage prepaid and properly addressed to the party to be
notified. 
 13. Successors and Assigns.    Except to the extent otherwise
provided in this Agreement, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the Corporation and its successors and assigns and Participant and Participant’s assigns. 

14. Governing Law.    The interpretation, performance and enforcement of this
Agreement shall be governed by the laws of the State of California without resort to that State’s conflict-of-laws rules. 

15. Employment at Will.    Nothing in this Agreement shall confer upon Participant any
right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Corporation (or any Parent or Subsidiary employing or retaining Participant) or of Participant, which rights are
hereby expressly reserved by each, to terminate Participant’s Service at any time for any reason, with or without cause. 

16. Participant Undertaking.    Participant hereby agrees to take whatever additional
action and execute whatever additional documents the Corporation may deem necessary or advisable in order to carry out or effect one or more of the obligations or 

 

 8 

 
restrictions imposed on either Participant or the issued Shares pursuant to the provisions of this Agreement. 

IN WITNESS WHEREOF, the parties have executed this Agreement on the day and year first indicated above.

  

			
	 AMYRIS BIOTECHNOLOGIES, INC.

 

		
	 By:            
	 	 
		
	 Title:
	 	 

  

			
	 LIT TELE LLC, PARTICIPANT

	
	 Signature:

	
	 Title:

		
	 Signature:  
	 	 
		
	 Title:
	 	 
		
	 Address:
	 	 

  

 8 

 APPENDIX A 

DEFINITIONS 

The following definitions shall be in effect under the Agreement: 

A. Agreement shall mean this Restricted Stock Unit Issuance Agreement. 

B. Award shall mean the award of Restricted Stock Units made to Participant pursuant to the terms of this
Agreement. 
 C. Award Date shall mean the date the Restricted Stock Units are awarded to
Participant pursuant to the Agreement and shall be the date indicated in Section 1 of the Agreement. 
 D.
Board shall mean the Corporation’s Board of Directors. 
 E. Change in Control
shall mean a change in ownership or control of the Corporation effected through any of the following transactions: 

(i)        a merger, consolidation or other reorganization
approved by the Corporation’s stockholders, unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially
owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Corporation’s outstanding voting securities immediately prior to such transaction, or 

(ii)        a stockholder-approved sale, transfer or other
disposition of all or substantially all of the Corporation’s assets in liquidation or dissolution of the Corporation, or 

(iii)        the acquisition, directly or indirectly by any
person or related group of persons (other than the Corporation or a person that directly or indirectly controls, is controlled by, or is under common control with, the Corporation), of beneficial ownership (within the meaning of Rule 13d-3 of the
1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Corporation’s outstanding securities pursuant to a tender or exchange offer made directly to the Corporation’s stockholders.

 In no event shall any public offering of the Corporation’s securities be deemed to constitute a Change
in Control. 
 F. Code shall mean the Internal Revenue Code of 1986, as amended. 

G. Common Stock shall mean shares of the Corporation’s common stock. 

 

 A-1 

 H. Corporation shall mean Amyris Biotechnologies, Inc., a
California corporation, and any successor corporation to all or substantially all of the assets or voting stock of Amyris Biotechnologies, Inc. 

I. Disposition Notice shall have the meaning assigned to such term in Section 10(b). 

J. Exercise Notice shall have the meaning assigned to such term in Section 10(c). 

K. Fair Market Value per share of Common Stock on any relevant date shall be determined in accordance with
the following provisions: 
 (i)         If the Common
Stock is at the time traded on the Nasdaq Global or Global Select Market, then the Fair Market Value shall be the closing selling price per share of Common Stock on the date in question, as such price is reported by the National Association of
Securities Dealers for that particular Stock Exchange and published in The Wall Street Journal. If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price
on the last preceding date for which such quotation exists. 
 (ii)    If
the Common Stock is at the time listed on any other Stock Exchange, then the Fair Market Value shall be the closing selling price per share of Common Stock on the date in question on the Stock Exchange determined by the Board to be the primary
market for the Common Stock, as such price is officially quoted in the composite tape of transactions on such exchange and published in The Wall Street Journal. If there is no closing selling price for the Common Stock on the date in
question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists. 

(iii)        If the Common Stock is not at the time neither
listed on any Stock Exchange, then the Fair Market Value shall be determined by the Board after taking into account such factors as the Board shall deem appropriate. 

L. First Refusal Right shall have the meaning assigned to such term in Section 10. 

M. Market Stand-Off shall mean the market stand-off restriction specified in Section 9. 

N. Misconduct shall mean the commission of any act of fraud, embezzlement or dishonesty by Participant or
Participant’s agents, any unauthorized use or disclosure by such person of confidential information or trade secrets of the Corporation (or any Parent or Subsidiary), or any other intentional misconduct by Participant or its agents adversely
affecting the business or affairs of the Corporation (or any Parent or Subsidiary) in 
  

 A-2 

 
a material manner. The foregoing definition shall not be deemed to be inclusive of all the acts or omissions which the Corporation (or any Parent or Subsidiary) may consider as grounds for the
dismissal or discharge of any optionee, participant or other person in the service of the Corporation (or any Parent or Subsidiary). 

O. 1934 Act shall mean the Securities Exchange Act of 1934, as amended from time to time. 

P. Parent shall mean any corporation (other than the Corporation) in an unbroken chain of corporations
ending with the Corporation, provided each corporation in the unbroken chain (other than the Corporation) owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of
stock in one of the other corporations in such chain. 
 Q. Recapitalization shall mean any stock
split, stock dividend, recapitalization, combination of shares, exchange of shares or other change affecting the Corporation’s outstanding Common Stock as a class without the Corporation’s receipt of consideration. 

R. Reorganization shall mean any of the following transactions: 

(i)        a merger or consolidation in which the Corporation is
not the surviving entity, 
 (ii)       a sale, transfer or other
disposition of all or substantially all of the Corporation’s assets, 

(iii)      a reverse merger in which the Corporation is the surviving entity but
in which the Corporation’s outstanding voting securities are transferred in whole or in part to a person or persons different from the persons holding those securities immediately prior to the merger, or 

(iv)      any transaction effected primarily to change the state in which the
Corporation is incorporated or to create a holding company structure. 
 S. Restricted Stock Unit
shall mean each unit subject to this Award which shall entitle Participant to receive one share of Common Stock at a designated time following the vesting of that unit. 

T. Service shall mean Participant’s performance of services for the Corporation (or any Parent or
Subsidiary) pursuant to the Advisory Service Agreement between the Corporation and Participant dated September [    ], 2008. For purposes of this Agreement, Participant shall be deemed to cease Service immediately upon the
occurrence of the either of the following events: (i) Participant no longer performs services in the foregoing capacity for the Corporation (or any Parent or Subsidiary) or (ii) the entity for which Participant performs such services
ceases to remain a Parent or Subsidiary of the 
  

 A-3 

 
Corporation, even though Participant may subsequently continue to perform services for that entity. 

U. Stock Exchange shall mean the American Stock Exchange, the Nasdaq Global or Global Select Market or the
New York Stock Exchange. 
 V. Subsidiary shall mean any corporation (other than the Corporation)
in an unbroken chain of corporations beginning with the Corporation, provided each corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing fifty percent (50%) or more of the
total combined voting power of all classes of stock in one of the other corporations in such chain. 
 W.
Target Shares shall have the meaning assigned to such term in Section 10(b). 
 X.
Withholding Taxes shall mean the employment taxes, social security taxes, social insurance, payroll taxes, contributions, payment on account obligations, national taxes and other applicable taxes and payments required to be withheld by
the Corporation in connection with the vesting of the shares of Common Stock under the Award or the issuance of shares of Common Stock under the Award. 
  

 A-4 

 EXHIBIT A 

INVESTMENT REPRESENTATION STATEMENT 
  

					
	 Participant:
	  	  
	  	
			
	 Corporation:
	  	  
	  	
		
	 Security:
	  	 _______________ shares of Common Stock (“Shares”)

			
	 Date:
	  	  
	  	

 Representations: In connection with the issuance of the Shares, Participant hereby
represents to the Corporation as follows: 
 (i)        The Shares have
not been registered under the 1933 Act and are being issued to Participant in reliance upon the exemption from such registration provided by Section 4(2) of the 1933 Act. Participant hereby confirms that Participant has been informed that the
Shares are restricted securities under the 1933 Act and may not be resold or transferred unless the Shares are first registered under the Federal securities laws or unless an exemption from such registration is available. 

(ii)        Participant is acquiring the Shares solely for investment purposes
for Participant’s own account, and not as a nominee or agent and with no present intention of distributing, reselling, granting any participation in or otherwise distributing any of the Shares or any interest therein other than pursuant to the
1933 Act. Participant does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant a participating interest in, any of the Shares. 

(iii)        Participant is aware of the Corporation’s business affairs and
financial condition and has been furnished with, and has had access to, such information as Participant considers necessary or appropriate for deciding whether to invest in the Shares. Participant has had an opportunity to ask questions and receive
answers from the Corporation regarding the terms and conditions of the issuance of the Shares. 

(iv)        Participant understands that the Shares are “restricted
securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, Participant must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state
authorities, or unless an exemption from such registration and qualification requirements is available. Participant acknowledges that the Corporation has no obligation to register or qualify the Shares for resale. Participant further acknowledges
that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and requirements relating to the
Corporation which are outside of Participant’s control, and which the Corporation is under no obligation to and may not be able to satisfy. 
  

 A-5 

 (v)        Participant understands
that there is no public market for the Shares, that no market may ever develop for them, and that the Shares have not been approved or disapproved by the Securities and Exchange Commission or any governmental agency. 

(vi)        Participant understands that the Shares are subject to certain
restrictions on transfer set forth in the Restricted Stock Unit Agreement between the Corporation and Participant dated as of September [    ], 2008 (the “Agreement”). 

(vii)        Participant is able to fend for itself in the transactions
contemplated by the Agreement, can bear the economic risk of investment in the Shares and has such knowledge and experience in financial or business matters to be capable of evaluating the merits and risks of the investment in the Shares.

 (viii)        If Participant is not a United States person (as
defined by Section 7701(a)(30) of the Internal Revenue Code), Participant represents that it has satisfied itself to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares, including
the legal requirements within its jurisdiction for the purchase of the Shares, any foreign exchange restrictions applicable to such purchase, any governmental or other consents that may need to be obtained and any income tax and other tax
consequences, if any, that may be relevant to the purchase, holding, sale or transfer of the Shares. Participant’s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other
laws of Participant’s jurisdiction. 
 (ix)        Participant has
read the following definition of “Accredited Investor” from Rule 501 of Regulation D and certifies that Participant is an “Accredited Investor:” 

Accredited Investor. “Accredited investor” shall mean any person who comes within any of the
following categories, or who the issuer reasonably believes comes within any of the following categories, at the time of the sale of the securities to that person: 

•        Any natural person whose individual net worth, or joint net worth
with that person’s spouse, at the time of his purchase exceeds $1,000,000 

•        Any natural person who had an individual income in excess of
$200,000 in each of the two most recent years or joint income with that person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year 

•        Any bank as defined in section 3(a)(2) of the Securities Act of
1933, as amended, (the “Act”) or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Act whether acting in its individual or fiduciary capacity; any broker dealer registered pursuant to
Section 15 of the Securities Exchange Act of 1934; any insurance company as defined in Section 2(13) of the Act; any investment company registered under the Investment Company Act of 1940 or a business development company as defined in
Section 2(a)(48) of that Act; any Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small 

 

 A-6 

 
Business Investment Act of 1958; any employee benefit plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974, if the investment decision is made by a plan
fiduciary, as defined in Section 3(21) of such Act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000; or, if a
self-directed plan, with investment decisions made solely by persons that are accredited investors 

•        Any private business development company as defined in
Section 202(a)(22) of the Investment Advisers Act of 1940 (a U.S. venture capital fund which invests primarily through private placements in non-publicly traded securities and makes available (either directly or through co-investors) to the
portfolio companies significant guidance concerning management, operations or business objectives) 

•        Any organization described in Section 501(c)(3) of the
Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000 

•        Any director, executive officer or general partner of the issuer
of the securities being offered or sold, or any director, executive officer or general partner of a general partner of that issuer 

•        Any trust with total assets in excess of $5,000,000, not formed
for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2)(ii) 

•        Any entity in which all of the equity owners are accredited
investors 
  

 A-7Amendment No.1 to Restated Strategic Advisory Services Agreement - Lit Tele LLC

 Exhibit 10.11 

AMYRIS BIOTECHNOLOGIES, INC. 

AMENDMENT NO. 1 TO 

AMENDED AND RESTATED STRATEGIC ADVISORY SERVICES AGREEMENT 

THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED STRATEGIC ADVISORY SERVICES AGREEMENT, by and between Amyris
Biotechnologies, Inc., a California corporation (the “Company”), and Lit Tele LLC, a Delaware limited liability company (“Lit Tele”), is dated as of February 11, 2010 (this “Amendment”), and
amends that certain Amended and Restated Strategic Advisory Services Agreement, by and between the Company and Lit Tele, dated as of July 31, 2009 (the “Agreement”). Capitalized terms used and not defined herein shall have
those meanings given to them in the Agreement. 
 WHEREAS, the Company and Lit Tele entered into the Agreement
in connection with the sale and issuance of shares of the Company’s Series C Preferred Stock pursuant to that certain Series C Preferred Stock Purchase Agreement dated as of July 31, 2009 (the “Purchase Agreement”);

 WHEREAS, in consideration of Lit Tele entering into the Purchase Agreement and in order to clarify the
number of warrants Lit Tele is eligible to receive under the Agreement, the parties have agreed to enter into this Amendment; and 

WHEREAS, this Amendment has been signed and delivered by the Company and Lit Tele as set forth in Section 7(b) of
the Agreement. 
 NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS: 

1.         Amendment to
Section 2(a)(ii).  Section 2(a)(ii) of the Agreement is hereby amended and restated to read in its entirety as follows: 

“An additional grant of 126,272 RSUs (the “Additional RSU Grant,” and together with the Initial RSU
Grant, the “RSU Grants”). The Additional RSU Grant shall vest, except as specified under Sections 6(b) and 6(c) herein, in accordance with the terms and conditions set forth in the Restricted Stock Unit Issuance Agreement attached
hereto as Exhibit A. 
 Such RSU Grants shall be inclusive of all fees and expenses and, except as set forth below or otherwise
agreed by Amyris in writing, shall be Lit Tele’s sole compensation for rendering the Strategic Advisory Services to Amyris. The parties hereto intend that the RSU Grants shall be without withholding or deduction for any U.S. tax.”

 2.         Full Force and Effect.  Except as
expressly modified by this Amendment, the terms of the Agreement remain in full force and effect. 

3.         Consent to this Amendment.  The execution of this
Amendment by the Company and Lit Tele shall be deemed, for purposes of Section 7(b) of the Agreement, to be their mutual written consent to amend the Agreement as set forth therein. 

 4.         Governing
Law.  This Amendment shall be governed by the laws of the State of California, as such laws are applied to contracts entered into and to be performed within such state, without regard to any conflicts of laws provisions. For purposes
of Brazilian conflict of law rules, the Parties acknowledge and agree that the Company is the proponent of the transaction embodied herein. 

5.         Counterparts.  This Amendment may be executed in two
or more counterparts, including counterparts transmitted by facsimile, other electronic transmission or otherwise, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 

6.         Successors and Assigns.  Neither this Amendment nor
any right hereunder or interest herein may be assigned or transferred by Lit Tele without the express prior written consent of an officer of the Company. This Amendment will be binding upon Lit Tele’s heirs, executors, administrators and other
legal representatives and will be for the benefit of the Company, its successors, and its assigns. 

7.         Prevailing Party.  If any action at law or in equity
is necessary to enforce or interpret the terms of this Amendment, the prevailing party shall be entitled to reasonable attorneys’ fees, costs, and necessary disbursements, in addition to any other relief to which the party may be entitled

 8.         Entire Agreement.  This Amendment and the
Agreement, along with the Purchase Agreement and the other documents delivered pursuant thereto, constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof and thereof and no party shall be
liable or bound to any other in any manner by any oral or written representations, warranties, covenants or agreements except as specifically set forth herein and therein. 

[Signature Pages Follow] 
  

 2 

 IN WITNESS WHEREOF, the parties have executed this Amendment No. 1 to
Amended and Restated Strategic Advisory Services Agreement as of the date first above written. 
  

			
	 COMPANY:

 
 AMYRIS BIOTECHNOLOGIES,
INC.

		
	 By:
	 	 /s/ John G. Melo

		 	 John G. Melo 

Chief Executive Officer 

 

			
		
	 Address:
	 	 5885 Hollis Street, Ste. 100

Emeryville, CA 94608

		 	

  
  

 
  

AMENDMENT NO. 1 TO AMENDED AND RESTATED STRATEGIC ADVISORY SERVICES AGREEMENT 

SIGNATURE PAGE 

 IN WITNESS WHEREOF, the parties have executed this Amendment No. 1 to
Amended and Restated Strategic Advisory Services Agreement as of the date first above written. 
  

			
	 LIT TELE:

 
 LIT TELE LLC

		
	 By:
	 	 /s/ Fernando Reinach

		 	 Fernando C. Reinach 

Authorized Signatory 

 

			
	 Address:
	 	 3411 Silverside Road

Rodney Building #104

Wilmington, DE 19810

		 	

  
  

 
  

AMENDMENT NO. 1 TO AMENDED AND RESTATED STRATEGIC ADVISORY SERVICES AGREEMENT 

SIGNATURE PAGE 

 EXHIBIT A 

Form of Restricted Stock Unit Agreement 

AMYRIS BIOTECHNOLOGIES, INC. 

RESTRICTED STOCK UNIT ISSUANCE AGREEMENT 

1.   Grant of Restricted Stock Units.  The Corporation hereby awards to the
Participant, as of the Award Date, Restricted Stock Units. Each Restricted Stock Unit which vests pursuant to the vesting schedule set forth below shall entitle Participant to receive one share of Common Stock on the specified issuance date. The
number of shares of Common Stock subject to the awarded Restricted Stock Units, the applicable vesting schedule for those shares, the date on which those vested shares shall become issuable to Participant and the remaining terms and conditions
governing the award (the “Award”) shall be as set forth in this Agreement. All capitalized terms in this Agreement shall have the meaning assigned to them in the attached Appendix A. 

AWARD SUMMARY 
  

			
	 Participant:
	  	 Lit Tele LLC

		
	 Award Date:
	  	 February 11, 2010

		
	 Number of Shares Subject to Award:
	  	 The maximum number of shares of Common Stock subject to this Award is 126,272 (the “Shares”). However, the actual number of shares of Common Stock
issuable pursuant to this Award shall be determined in accordance with the Vesting Schedule set forth below.

		
	 Vesting Schedule:
	  	 31,568 of the Shares shall vest on the following dates, provided Participant remains in the Corporation’s Service through each such vesting date:
December 31, 2009; March 31, 2010; June 30, 2010; and September 30, 2010. However, the Shares may be subject to accelerated vesting in whole or in part in accordance with the provisions of Paragraph 5 of this Agreement.

		
	 Issuance Schedule
	  	 Each Share in which Participant vests in accordance with the Vesting Schedule shall be issued, subject to Paragraph 8 of this Agreement and the
Corporation’s collection of all applicable Withholding Taxes, on the date that particular Share vests (the “Issuance Date”) or as soon after that

			
		  	 scheduled Issuance Date as administratively practicable. The Shares which vest pursuant to Paragraph 5 of this
Agreement shall be issued in accordance with the provisions of such Paragraph. In addition, any issued Shares shall be subject to the transfer restrictions of this Agreement.

 
 In no event shall any fractional shares be issued.
Accordingly the total number of Shares to be issued pursuant to the Award shall, to the extent necessary, be rounded down to the next whole Share.

2.  Limited Transferability.  Prior to actual receipt of the Shares which vest
and become issuable hereunder, Participant may not transfer any interest in the Award or the underlying Shares; however, the foregoing shall not apply to any transfer of interest in the Award or the underlying shares without consideration to any
person or entity, directly or indirectly, controlling, controlled by or under common control with, the Participant, provided that (A) the Participant shall inform the Corporation of such transfer prior to effecting it and (B) the
transferee shall enter into a written agreement to be bound by and comply with all provisions of this Agreement, as if it were the original participant hereunder. Any issued Shares shall be subject to the restrictions of Paragraphs 9 and 10 of this
Agreement. In addition, Participant shall make no disposition of any issued Shares unless and until there is compliance with all of the following requirements: (i) Participant shall have provided the Corporation with a written summary of the
terms and conditions of the proposed disposition; (ii) Participant shall have complied with all requirements of this Agreement applicable to the disposition of the Shares; and (iii) Participant shall have provided the Corporation with
written assurances, in form and substance satisfactory to the Corporation, that (a) the proposed disposition does not require registration of the Shares under the 1933 Act or (b) all appropriate action necessary for compliance with the
registration requirements of the 1933 Act or any exemption from registration available under the 1933 Act (including Rule 144) has been taken. 

3.  Cessation of Service.  Should Participant cease Service for any reason prior
to vesting in one or more Shares subject to this Award, then the Award will be immediately cancelled with respect to those unvested Shares, and the number of Restricted Stock Units will be reduced accordingly. Participant shall thereupon cease to
have any right or entitlement to receive any Shares under those cancelled units. Should Participant’s Service terminate by reason of Misconduct, then this Award will be immediately cancelled with respect to all the Restricted Stock Units
subject to such Award, whether vested or unvested at the time, and Participant shall thereupon cease to have any right or entitlement to receive any Shares under this Award and the cancelled Restricted Stock Units. 

4.  Stockholder Rights.  The holder of this Award shall not have any stockholder
rights, including voting or dividend rights, with respect to the Shares subject to the Award until Participant becomes the record holder of those Shares following their actual issuance upon the Corporation’s collection of the applicable
Withholding Taxes. 
  

 2 

 5.  Change of Control. 

(a) Any Restricted Stock Units subject to this Award at the time of a Change in Control may be assumed by the successor
entity or otherwise continued in full force and effect or may be replaced with a cash incentive program of the successor entity which preserves the Fair Market Value of the unvested shares of Common Stock subject to the Award at the time of the
Change in Control and provides for subsequent payout of that value in accordance with the vesting schedule applicable to the Award. In the event of such assumption or continuation of the Award or such replacement of the Award with a cash incentive
program, no accelerated vesting of the Restricted Stock Units shall occur at the time of the Change in Control. 

(b) In the event the Award is assumed or otherwise continued in effect, the Restricted Stock Units subject to the Award
shall be adjusted immediately after the consummation of the Change in Control so as to apply to the number and class of securities into which the Shares subject to those units immediately prior to the Change in Control would have been converted in
consummation of that Change in Control had those Shares actually been issued and outstanding at that time. To the extent the actual holders of the outstanding Common Stock receive cash consideration for their Common Stock in consummation of the
Change in Control, the successor corporation (or parent entity) may, in connection with the assumption or continuation of the Restricted Stock Units subject to the Award at that time and with Participant’s prior written consent, substitute one
or more shares of its own common stock with a fair market value equivalent to the cash consideration paid per share of Common Stock in the Change in Control transaction, provided the substituted common stock is readily tradable on an established
U.S. securities exchange or market. 
 (c) If the Restricted Stock Units subject to this Award at the time of
the Change in Control are not assumed or otherwise continued in effect or replaced with a cash incentive program under Section 6(a), then those units will vest immediately prior to the closing of the Change in Control. The Shares subject to
those vested units will be issued immediately upon such vesting (or otherwise converted into the right to receive the same consideration per share of Common Stock payable to the other stockholders of the Corporation in consummation of that Change in
Control), subject to the Corporation’s collection of the applicable Withholding Taxes. 
 (d) This
Agreement shall not in any way affect the right of the Corporation to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its
business or assets. 
 6.  Adjustment in Shares.  Should any change be made
to the Common Stock by reason of any stock split, stock dividend, recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without the Corporation’s receipt of consideration,
appropriate adjustments shall be made to the total number and/or class of securities issuable pursuant to this Award in order to reflect such change and thereby preclude a dilution or enlargement of benefits hereunder. 

 

 3 

 7.  Compliance with Laws and
Regulations.  The issuance of shares of Common Stock pursuant to the Award shall be subject to compliance by the Corporation and Participant with all applicable requirements of law relating thereto and with all applicable
regulations of any Stock Exchange on which the Common Stock may be listed for trading at the time of such issuance. 

8.  Representations.  At the time of issuance of the Shares, Participant shall,
if required by the Corporation, deliver to the Corporation Participant’s Investment Representation Statement in the form attached hereto as Exhibit A. 

9.  Market Stand-Off. 

(a) In connection with any underwritten public offering by the Corporation of its equity securities pursuant to an
effective registration statement filed under the 1933 Act, including the Corporation’s initial public offering, Participant shall not sell, make any short sale of, loan, hypothecate, pledge, grant any option for the purchase of, or otherwise
dispose or transfer for value or otherwise agree to engage in any of the foregoing transactions with respect to, any issued Shares without the prior written consent of the Corporation or its underwriters. Such restriction (the “Market
Stand-Off”) shall be in effect for such period of time from and after the effective date of the final prospectus for the offering as may be requested by the Corporation or such underwriters. In no event, however, shall such period exceed one
hundred eighty (180) days, and the Market Stand-Off shall in no event be applicable to any underwritten public offering effected more than two (2) years after the effective date of the Corporation’s initial public offering.

 (b) Participant shall be subject to the Market Stand-Off provided and only if the officers and directors of
the Corporation are also subject to similar restrictions. 
 (c) Any new, substituted or additional securities
which are by reason of any Recapitalization or Reorganization distributed with respect to the issued Shares shall be immediately subject to the Market Stand-Off, to the same extent the issued Shares are at such time covered by such provisions.

 (d) In order to enforce the Market Stand-Off, the Corporation may impose stop-transfer instructions with
respect to the issued Shares until the end of the applicable stand-off period. 
 10.  Right of
First Refusal 
 (a)  Grant.    The
Corporation is hereby granted the right of first refusal (the “First Refusal Right”), exercisable in connection with any proposed transfer of the Shares. For purposes of this Section 10, the term “transfer” shall include any
sale, assignment, pledge, encumbrance or other disposition of the Shares intended to be made by Participant. 
  

 4 

 (b)  Notice of Intended
Disposition.    In the event Participant desires to accept a bona fide third-party offer for the transfer of any or all of such shares (the Shares subject to such offer to be hereinafter referred to as the
“Target Shares”), Participant shall promptly (i) deliver to the Corporation written notice (the “Disposition Notice”) of the terms of the offer, including the purchase price and the identity of the third-party offeror, and
(ii) provide satisfactory proof that the disposition of the Target Shares to such third-party offeror would not be in contravention of the provisions of this Agreement. 

(c)  Exercise of the First Refusal Right.    The
Corporation shall, for a period of twenty-five (25) days following receipt of the Disposition Notice, have the right to repurchase any or all of the Target Shares subject to the Disposition Notice upon the same terms as those specified therein
or upon such other terms (not materially different from those specified in the Disposition Notice) to which Participant consents. Such right shall be exercisable by delivery of written notice (the “Exercise Notice”) to Participant prior to
the expiration of the twenty-five (25)-day exercise period. If such right is exercised with respect to all the Target Shares, then the Corporation shall effect the repurchase of such shares, including payment of the purchase price, not more than
five (5) business days after delivery of the Exercise Notice; and at such time the certificates representing the Target Shares shall be delivered to the Corporation. 

Should the purchase price specified in the Disposition Notice be payable in property other than cash or evidences of
indebtedness, the Corporation shall have the right to pay the purchase price in the form of cash equal in amount to the value of such property. If Participant and the Corporation cannot agree on such cash value within ten (10) days after the
Corporation’s receipt of the Disposition Notice, the valuation shall be made by an appraiser of recognized standing selected by Participant and the Corporation or, if they cannot agree on an appraiser within twenty (20) days after the
Corporation’s receipt of the Disposition Notice, each shall select an appraiser of recognized standing and the two (2) appraisers shall designate a third appraiser of recognized standing, whose appraisal shall be determinative of such
value. The cost of such appraisal shall be shared equally by Participant and the Corporation. The closing shall then be held on the later of (i) the fifth (5th) business day following delivery of the Exercise Notice or (ii) the fifth
(5th) business day after such valuation shall have been made. 

(d)  Non-Exercise of the First Refusal Right.    In the
event the Exercise Notice is not given to Participant prior to the expiration of the twenty-five (25)-day exercise period, Participant shall have a period of thirty (30) days thereafter in which to sell or otherwise dispose of the Target Shares
to the third-party offeror identified in the Disposition Notice upon terms (including the purchase price) no more favorable to such third-party offeror than those specified in the Disposition Notice; provided, however, that any such sale or
disposition must not be effected in contravention of the provisions of Paragraphs 2, 9 and 11 of this Agreement. The third-party offeror shall acquire the Target Shares subject to the First Refusal Right and the provisions and restrictions of
Paragraphs 2, 9 and 11, and any subsequent disposition of the acquired shares must be effected in compliance with the terms and conditions of such First Refusal Right and the provisions and restrictions of Paragraphs 2, 9 and 11. In the event
Participant does not effect such sale or disposition of the Target Shares within the specified thirty (30)-day period, the First Refusal Right shall 

 

 5 

 
continue to be applicable to any subsequent disposition of the Target Shares by Participant until such right lapses. 

(e) Partial Exercise of the First Refusal Right. In the event the Corporation makes a
timely exercise of the First Refusal Right with respect to a portion, but not all, of the Target Shares specified in the Disposition Notice, Participant shall have the option, exercisable by written notice to the Corporation delivered within five
(5) business days after Participant’s receipt of the Exercise Notice, to effect the sale of the Target Shares pursuant to either of the following alternatives: 

(i)        sale or other disposition of all the Target Shares to
the third-party offeror identified in the Disposition Notice, but in full compliance with the requirements of Section 10(d), as if the Corporation did not exercise the First Refusal Right; or 

(ii) sale to the Corporation of the portion of the Target Shares which the Corporation has elected to
purchase, such sale to be effected in substantial conformity with the provisions of Section 10(c). The First Refusal Right shall continue to be applicable to any subsequent disposition of the remaining Target Shares until such right lapses.

 Participant’s failure to deliver timely notification to the Corporation shall be deemed to be an
election by Participant to sell the Target Shares pursuant to alternative (i) above. 
 (f)
Recapitalization/Reorganization. 

(i)        Any new, substituted or additional securities or
other property which is by reason of any Recapitalization distributed with respect to the issued Shares shall be immediately subject to the First Refusal Right, but only to the extent the issued Shares are at the time covered by such right.

 (ii)        In the event of a Reorganization, the
First Refusal Right shall remain in full force and effect and shall apply to the new capital stock or other property received in exchange for the issued Shares in consummation of the Reorganization, but only to the extent the issued Shares are at
the time covered by such right. 
 (g) Lapse. The First Refusal Right shall
lapse upon the earliest to occur of (i) the first date on which shares of the Common Stock are held of record by more than five hundred (500) persons, (ii) a determination made by the Board that a public market exists for the
outstanding shares of Common Stock or (iii) a firm commitment underwritten public offering, pursuant to an effective registration statement under the 1933 Act, covering the offer and sale of the Common Stock in the aggregate amount of at least
twenty million dollars ($20,000,000). However, the Market Stand-Off shall continue to remain in full force and effect following the lapse of the First Refusal Right. 

 

 6 

 (h)  No
Waiver.    The failure of the Corporation in any instance to exercise the First Refusal Right shall not constitute a waiver of any other repurchase rights and/or rights of first refusal that may subsequently
arise under the provisions of this Agreement or any other agreement between the Corporation and Participant. No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition,
whether of like or different nature. 
 (i)  Cancellation of
Shares.    If the Corporation shall make available, at the time and place and in the amount and form provided in this Agreement, the consideration for the Shares to be repurchased in accordance with the
provisions of this Agreement, then from and after such time, the person from whom such shares are to be repurchased shall no longer have any rights as a holder of such shares (other than the right to receive payment of such consideration in
accordance with this Agreement). Such shares shall be deemed purchased in accordance with the applicable provisions hereof, and the Corporation shall be deemed the owner and holder of such shares, whether or not the certificates therefor have been
delivered as required by this Agreement. 
 (j)    Exempted
Transfers.    Notwithstanding the foregoing, the First Refusal Right of the Corporation set forth in this Section 10 shall not apply to any transfer without consideration to any person or entity,
directly or indirectly, controlling, controlled by or under common control with the Participant; provided that (A) the Participant shall inform the Corporation of such transfer prior to effecting it and (B) the transferee shall enter into
a written agreement to be bound by and comply with all provisions of this Agreement, as if it were the original participant hereunder. Such transferred Shares shall remain “Shares” hereunder, and such transferee shall be treated as the
“Participant” for purposes of this Agreement. 
 11.  Restrictive Legends and Refusal
to Transfer. 
 (a) The stock certificates for the Shares shall be endorsed with one or more of the
following restrictive legends: 
 “The shares represented by this certificate have not been registered under the Securities
Act of 1933. The shares may not be sold or offered for sale in the absence of (a) an effective registration statement for the shares under such Act, (b) a ‘no action’ letter of the Securities and Exchange Commission with respect
to such sale or offer or (c) satisfactory assurances to the Corporation that registration under such Act is not required with respect to such sale or offer.” 
  

 7 

 “The shares represented by this certificate are subject to certain rights of first
refusal granted to the Corporation and accordingly may not be sold, assigned, transferred, encumbered, or in any manner disposed of except in conformity with the terms of a written agreement dated July 31, 2009, between the Corporation and the
registered holder of the shares (or the predecessor in interest to the shares). A copy of such agreement is maintained at the Corporation’s principal corporate offices.” 

(b) The Corporation shall not be required (i) to transfer on its books any Shares which have been sold or
transferred in violation of the provisions of this Agreement or (ii) to treat as the owner of the Shares, or otherwise to accord voting, dividend or liquidation rights to, any transferee to whom the Shares have been transferred in contravention
of this Agreement. 
 12. Notices.  Any notice required to be given or delivered to the
Corporation under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal corporate offices. Any notice required to be given or delivered to Participant shall be in writing and addressed to Participant at
the address indicated below Participant’s signature line on this Agreement. All notices shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, postage prepaid and properly addressed to the party to be notified.

 13. Successors and Assigns.  Except to the extent otherwise provided in this
Agreement, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the Corporation and its successors and assigns and Participant and Participant’s assigns. 

14. Governing Law.  The interpretation, performance and enforcement of this Agreement shall be
governed by the laws of the State of California without resort to that State’s conflict-of-laws rules. 

15. Employment at Will.  Nothing in this Agreement shall confer upon Participant any right to
continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Corporation (or any Parent or Subsidiary employing or retaining Participant) or of Participant, which rights are hereby
expressly reserved by each, to terminate Participant’s Service at any time for any reason, with or without cause. 

16. Participant Undertaking.  Participant hereby agrees to take whatever additional action and
execute whatever additional documents the Corporation may deem necessary or advisable in order to carry out or effect one or more of the obligations or 

 

 8 

 
restrictions imposed on either Participant or the issued Shares pursuant to the provisions of this Agreement. 

IN WITNESS WHEREOF, the parties have executed this Agreement on the day and year first indicated above.

  

			
	 AMYRIS BIOTECHNOLOGIES, INC.

 

		
	 By:            
	 	 
		
	 Title:
	 	 

  

			
	 LIT TELE LLC, PARTICIPANT

	
	 Signature:

	
	 Title:

		
	 Signature:
	 	 
		
	 Title:
	 	 
		
	 Address:
	 	 
		
		 	 

  

 9 

 APPENDIX A 

DEFINITIONS 

The following definitions shall be in effect under the Agreement: 

A. Agreement shall mean this Restricted Stock Unit Issuance Agreement. 

B. Award shall mean the award of Restricted Stock Units made to Participant pursuant to the terms of this
Agreement. 
 C. Award Date shall mean the date the Restricted Stock Units are awarded to
Participant pursuant to the Agreement and shall be the date indicated in Section 1 of the Agreement. 
 D.
Board shall mean the Corporation’s Board of Directors. 
 E. Change in Control
shall mean a change in ownership or control of the Corporation effected through any of the following transactions: 

(i)        a merger, consolidation or other reorganization
approved by the Corporation’s stockholders, unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially
owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Corporation’s outstanding voting securities immediately prior to such transaction, or 

(ii)        a stockholder-approved sale, transfer or other
disposition of all or substantially all of the Corporation’s assets in liquidation or dissolution of the Corporation, or 

(iii)        the acquisition, directly or indirectly by any
person or related group of persons (other than the Corporation or a person that directly or indirectly controls, is controlled by, or is under common control with, the Corporation), of beneficial ownership (within the meaning of Rule 13d-3 of the
1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Corporation’s outstanding securities pursuant to a tender or exchange offer made directly to the Corporation’s stockholders.

 In no event shall any public offering of the Corporation’s securities be deemed to constitute a Change
in Control. 
 F. Code shall mean the Internal Revenue Code of 1986, as amended. 

G. Common Stock shall mean shares of the Corporation’s common stock. 

 H. Corporation shall mean Amyris Biotechnologies, Inc., a
California corporation, and any successor corporation to all or substantially all of the assets or voting stock of Amyris Biotechnologies, Inc. 

I. Disposition Notice shall have the meaning assigned to such term in Section 10(b). 

J. Exercise Notice shall have the meaning assigned to such term in Section 10(c). 

K. Fair Market Value per share of Common Stock on any relevant date shall be determined in accordance with
the following provisions: 
 (i)        If the Common
Stock is at the time traded on the Nasdaq Global or Global Select Market, then the Fair Market Value shall be the closing selling price per share of Common Stock on the date in question, as such price is reported by the National Association of
Securities Dealers for that particular Stock Exchange and published in The Wall Street Journal. If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price
on the last preceding date for which such quotation exists. 

(ii)        If the Common Stock is at the time listed on any
other Stock Exchange, then the Fair Market Value shall be the closing selling price per share of Common Stock on the date in question on the Stock Exchange determined by the Board to be the primary market for the Common Stock, as such price is
officially quoted in the composite tape of transactions on such exchange and published in The Wall Street Journal. If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the
closing selling price on the last preceding date for which such quotation exists. 

(iii)        If the Common Stock is not at the time neither
listed on any Stock Exchange, then the Fair Market Value shall be determined by the Board after taking into account such factors as the Board shall deem appropriate. 

L. First Refusal Right shall have the meaning assigned to such term in Section 10. 

M. Market Stand-Off shall mean the market stand-off restriction specified in Section 9. 

N. Misconduct shall mean the commission of any act of fraud, embezzlement or dishonesty by Participant or
Participant’s agents, any unauthorized use or disclosure by such person of confidential information or trade secrets of the Corporation (or any Parent or Subsidiary), or any other intentional misconduct by Participant or its agents adversely
affecting the business or affairs of the Corporation (or any Parent or Subsidiary) in 
  

 A-2 

 
a material manner. The foregoing definition shall not be deemed to be inclusive of all the acts or omissions which the Corporation (or any Parent or Subsidiary) may consider as grounds for the
dismissal or discharge of any optionee, participant or other person in the service of the Corporation (or any Parent or Subsidiary). 

O. 1934 Act shall mean the Securities Exchange Act of 1934, as amended from time to time. 

P. Parent shall mean any corporation (other than the Corporation) in an unbroken chain of corporations
ending with the Corporation, provided each corporation in the unbroken chain (other than the Corporation) owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of
stock in one of the other corporations in such chain. 
 Q. Recapitalization shall mean any stock
split, stock dividend, recapitalization, combination of shares, exchange of shares or other change affecting the Corporation’s outstanding Common Stock as a class without the Corporation’s receipt of consideration. 

R. Reorganization shall mean any of the following transactions: 

(i)        a merger or consolidation in which the Corporation is
not the surviving entity, 
 (ii)        a sale,
transfer or other disposition of all or substantially all of the Corporation’s assets, 

(iii)        a reverse merger in which the Corporation is the
surviving entity but in which the Corporation’s outstanding voting securities are transferred in whole or in part to a person or persons different from the persons holding those securities immediately prior to the merger, or 

(iv)        any transaction effected primarily to change the
state in which the Corporation is incorporated or to create a holding company structure. 
 S. Restricted
Stock Unit shall mean each unit subject to this Award which shall entitle Participant to receive one share of Common Stock at a designated time following the vesting of that unit. 

T. Service shall mean Participant’s performance of services for the Corporation (or any Parent or
Subsidiary) pursuant to the Amended and Restated Advisory Services Agreement between the Corporation and Participant dated July 31, 2009. For purposes of this Agreement, Participant shall be deemed to cease Service immediately upon the
occurrence of the either of the following events: (i) Participant no longer performs services in the foregoing capacity for the Corporation (or any Parent or Subsidiary) or (ii) the entity for which Participant performs such services
ceases to remain a Parent or Subsidiary of 
  

 A-3 

 
the Corporation, even though Participant may subsequently continue to perform services for that entity. 

U. Stock Exchange shall mean the American Stock Exchange, the Nasdaq Global or Global Select Market or the
New York Stock Exchange. 
 V. Subsidiary shall mean any corporation (other than the Corporation)
in an unbroken chain of corporations beginning with the Corporation, provided each corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing fifty percent (50%) or more of the
total combined voting power of all classes of stock in one of the other corporations in such chain. 
 W.
Target Shares shall have the meaning assigned to such term in Section 10(b). 
 X.
Withholding Taxes shall mean the employment taxes, social security taxes, social insurance, payroll taxes, contributions, payment on account obligations, national taxes and other applicable taxes and payments required to be withheld by
the Corporation in connection with the vesting of the shares of Common Stock under the Award or the issuance of shares of Common Stock under the Award. 
  

 A-4 

 EXHIBIT A 

INVESTMENT REPRESENTATION STATEMENT 
  

					
	 Participant:
	  	 	  	
			
	 Corporation:
	  	 	  	
		
	 Security:
	  	 _______________ shares of Common Stock (“Shares”)

			
	 Date:
	  	 	  	

 Representations: In connection with the issuance of the Shares, Participant hereby
represents to the Corporation as follows: 
 (i)        The Shares have
not been registered under the 1933 Act and are being issued to Participant in reliance upon the exemption from such registration provided by Section 4(2) of the 1933 Act. Participant hereby confirms that Participant has been informed that the
Shares are restricted securities under the 1933 Act and may not be resold or transferred unless the Shares are first registered under the Federal securities laws or unless an exemption from such registration is available. 

(ii)        Participant is acquiring the Shares solely for investment purposes
for Participant’s own account, and not as a nominee or agent and with no present intention of distributing, reselling, granting any participation in or otherwise distributing any of the Shares or any interest therein other than pursuant to the
1933 Act. Participant does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant a participating interest in, any of the Shares. 

(iii)        Participant is aware of the Corporation’s business affairs and
financial condition and has been furnished with, and has had access to, such information as Participant considers necessary or appropriate for deciding whether to invest in the Shares. Participant has had an opportunity to ask questions and receive
answers from the Corporation regarding the terms and conditions of the issuance of the Shares. 

(iv)        Participant understands that the Shares are “restricted
securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, Participant must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state
authorities, or unless an exemption from such registration and qualification requirements is available. Participant acknowledges that the Corporation has no obligation to register or qualify the Shares for resale. Participant further acknowledges
that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and requirements relating to the
Corporation which are outside of Participant’s control, and which the Corporation is under no obligation to and may not be able to satisfy. 

 (v)        Participant understands
that there is no public market for the Shares, that no market may ever develop for them, and that the Shares have not been approved or disapproved by the Securities and Exchange Commission or any governmental agency. 

(vi)        Participant understands that the Shares are subject to certain
restrictions on transfer set forth in the Restricted Stock Unit Agreement between the Corporation and Participant dated as of
[                        ], 20[    ] (the “Agreement”). 

(vii)        Participant is able to fend for itself in the transactions
contemplated by the Agreement, can bear the economic risk of investment in the Shares and has such knowledge and experience in financial or business matters to be capable of evaluating the merits and risks of the investment in the Shares.

 (viii)        If Participant is not a United States person (as
defined by Section 7701(a)(30) of the Internal Revenue Code), Participant represents that it has satisfied itself to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares, including
the legal requirements within its jurisdiction for the purchase of the Shares, any foreign exchange restrictions applicable to such purchase, any governmental or other consents that may need to be obtained and any income tax and other tax
consequences, if any, that may be relevant to the purchase, holding, sale or transfer of the Shares. Participant’s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other
laws of Participant’s jurisdiction. 
 (ix)        Participant has
read the following definition of “Accredited Investor” from Rule 501 of Regulation D and certifies that Participant is an “Accredited Investor:” 

Accredited Investor. “Accredited investor” shall mean any person who comes within any of the
following categories, or who the issuer reasonably believes comes within any of the following categories, at the time of the sale of the securities to that person: 

•        Any natural person whose individual net worth, or joint net worth
with that person’s spouse, at the time of his purchase exceeds $1,000,000 

•        Any natural person who had an individual income in excess of
$200,000 in each of the two most recent years or joint income with that person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year 

•         Any bank as defined in section 3(a)(2) of the Securities Act of
1933, as amended, (the “Act”) or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Act whether acting in its individual or fiduciary capacity; any broker dealer registered pursuant to
Section 15 of the Securities Exchange Act of 1934; any insurance company as defined in Section 2(13) of the Act; any investment company registered under the Investment Company Act of 1940 or a business development company as defined in
Section 2(a)(48) of that Act; any Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small 

 

 A-2 

 
Business Investment Act of 1958; any employee benefit plan within the meaning of Title I of the Employee Retirement Income Security Act of 1974, if the investment decision is made by a plan
fiduciary, as defined in Section 3(21) of such Act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000; or, if a
self-directed plan, with investment decisions made solely by persons that are accredited investors 

•        any private business development company as defined in
Section 202(a)(22) of the Investment Advisers Act of 1940 (a U.S. venture capital fund which invests primarily through private placements in non-publicly traded securities and makes available (either directly or through co-investors) to the
portfolio companies significant guidance concerning management, operations or business objectives) 

•        Any organization described in Section 501(c)(3) of the
Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000 

•        Any director, executive officer or general partner of the issuer of
the securities being offered or sold, or any director, executive officer or general partner of a general partner of that issuer 

•        Any trust with total assets in excess of $5,000,000, not formed for
the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2)(ii) 

•        Any entity in which all of the equity owners are accredited
investors 
  

 A-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}]]